Impact of improved HIV care and treatment on PrEP effectiveness in the United States, 2016-2020
Journal of Acquired Immune Deficiency Syndromes Jul 11, 2018
Khurana N, et al. - Researchers sought to assess the effect of improving diagnosis, care, and treatment of persons living with HIV (PLWH) on pre-exposure prophylaxis (PrEP) effectiveness in the United States. Using a dynamic, compartmental model that simulates the sexually active US population, they investigated the change in cumulative HIV incidence from 2016 to 2020 for 3 HIV care-continuum levels and the marginal benefit of PrEP compared with each. Observations revealed larger marginal benefit of PrEP when current HIV-care-continuum percentages were maintained but it continued to be substantial even when national care goals were met. PrEP seemed to benefit the high-risk men who have sex with men population chiefly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries